机构:[1]Tianjin University of Traditional Chinese Medicine, Tianjin, China.[2]Tianjin Second People's Hospital, Tianjin, China.[3]First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.[4]Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, China.[5]Tianjin First Central Hospital, Tianjin, China.[6]Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology, School of Life Sciences, Shandong University, Qingdao, China.
National Natural Science
Foundation of China (Nos 81703921 and 81973800), Science
and Technology Projects in Key Fields of Traditional Chinese
Medicine of Tianjin Municipal Health Commission (No.
2020006), Chunmiao Project of Tianjin First Central Hospital
(No. 2019CM15), Tianjin Medical Key Construction Discipline
Fund Project (No. 2021-492), the Key Research Project of
Traditional Chinese Medicine of Tianjin Municipal Health
Commission (202006).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|2 区医学
小类|2 区药学
最新[2023]版:
大类|2 区医学
小类|2 区药学
第一作者:
第一作者机构:[1]Tianjin University of Traditional Chinese Medicine, Tianjin, China.[2]Tianjin Second People's Hospital, Tianjin, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Yang Lu,Bi Liping,Jin Lulu,et al.Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism[J].Frontiers in pharmacology.2021,12:772635.doi:10.3389/fphar.2021.772635.
APA:
Yang Lu,Bi Liping,Jin Lulu,Wang Yuming,Li Yuting...&Wang Li.(2021).Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism.Frontiers in pharmacology,12,
MLA:
Yang Lu,et al."Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism".Frontiers in pharmacology 12.(2021):772635